Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-02-18
2009-12-08
Kim, Jennifer M (Department: 1617)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07629378
ABSTRACT:
Therapeutic compositions of doxepin and having a preponderance of the cis doxepin isomer over the trans doxepin isomer provide therapeutic effects for affective, painful, or allergic disorders without the sedative effects commonly experienced with compositions having a preponderance of the trans doxepin isomer.
REFERENCES:
patent: 4370324 (1983-01-01), Bernstein
patent: 4395420 (1983-07-01), Bernstein
patent: 4505909 (1985-03-01), Bernstein
patent: 4636125 (1987-01-01), Burgard
patent: 5502047 (1996-03-01), Kavey
patent: 6096738 (2000-08-01), Bernstein
patent: 1177406 (1984-11-01), None
patent: 1185179 (1985-04-01), None
patent: 1198059 (1985-12-01), None
Arzneim-Fosch; “Plasma Levels of the Cis-and Trans-Isomers of Doxepin and Desmethyldoxepin after Administration of Doxepin tp Patents”, Drug Res.31, vol. 1, pp. 113-115, 1981.
USP25, 2002; United States Pharmacopeia Convention, Inc. Rockville, MD, p. 614.
Midha et al., “Steroselective pharmacokinetics of doxepin isomers.”, European Journal of Clinical Pharmacology (1992), 42(5), pp. 539-544.
Otsuki et al., “Comparison of Pharmacological Activities of Doxepin Hydrochloride with Its Geometrical Isomers,”Oyo Yakuri, 6 (5): 973-984 (1972) (Abstract).
Pinder et al., “Doxepin Up-to-date: A Review of its Pharmacological Properties and Therapeutic Efficacy with Particular Reference to Depression,”Drugs, 13: 161-218 (1977).
Ross, CRC Handbook of Stereoisomers: Drugs in Pharmacology, “Antidepressant Drugs:(Z)-and(E)-Isomers,” CRC Press, Boca Raton, Fla., pp. 243-255 (1984).
Yan et al., “Absolute bioavailability an stereoselective pharmacokinetics of doxepin,”Xenobiotica, 32 (7): 615-623 (2001).
International Search Report issued in PCT/US2003/36600 (2004).
Page 1 of Office Action issued in GB2411356 (2005).
Barnes & Thornburg LLP
Gideon Pharmaceuticals, Inc.
Kim Jennifer M
Martin Alice O.
LandOfFree
Compositions and method for treating affective, painful or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and method for treating affective, painful or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and method for treating affective, painful or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4109325